Literature DB >> 31761052

F-containing initiatior for ultrasensitive fluorescent detection of lung cancer DNA via atom transfer radical polymerization.

Jingyu Zhang1, Qianrui Liu2, Yanyan Ba1, Jiamin Cheng1, Huaixia Yang3, Ying Cui4, Jinming Kong5, Xueji Zhang6.   

Abstract

An ultrasensitive fluorescence method for early diagnosis of lung cancer via Nafion-initiated atom transfer radical polymerization (ATRP) is reported, in this paper. In the proposed method, thiolated peptide nucleic acid (PNA) is modified to amino magnetic beads (MBs) via a cross-linking agent to specifically capture target DNA (tDNA), and the initiator (Nafion) of ATRP is attached to PNA/DNA heteroduplexes based on the phosphate groups of the tDNA and sulfonate groups of Nafion via phosphate-Zr4+-sulfonate chemistry. Nafion as a macroinitiator of ATRP possesses multiple C-F active sites to initiate polymerization, and numerous polymeric chains that significantly amplify the fluorescent signal are formed. Under optimal conditions, a good linear relationship is obtained in the range of 0.1 nM-0.1 fM with correlation coefficients of 0.9975, and the detection limit is as low as 35.5 aM (∼214 molecules). The proposed strategy has several advantages of simplicity, cost-effectiveness, selectivity and sensitivity. More importantly, the anti-interference results demonstrate that the proposed Nafion-initiated ATRP strategy has great potential in bioanalytical applications.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATRP; DNA; Fluorescence; Lung cancer; Nafion

Mesh:

Substances:

Year:  2019        PMID: 31761052     DOI: 10.1016/j.aca.2019.09.080

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  1 in total

Review 1.  Biorecognition Engineering Technologies for Cancer Diagnosis: A Systematic Literature Review of Non-Conventional and Plausible Sensor Development Methods.

Authors:  Kalaumari Mayoral-Peña; Omar Israel González Peña; Alexia María Orrantia Clark; Rosario Del Carmen Flores-Vallejo; Goldie Oza; Ashutosh Sharma; Marcos De Donato
Journal:  Cancers (Basel)       Date:  2022-04-07       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.